Fisher’s exact test p-values for this pathway suggested that there was a significant correlation between Akt signaling and CRTAC1-mediated cisplatin sensitivity in NSCLC cells (Fig. 4B). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.